A Prospective, Open, Comparative Multicentre Phase II Study for the Evaluation of Irinotecan and Capecitabine Versus Cisplatin and Capecitabine in Advanced Gastric Adenocarcinoma or Gastric-Oesophagal Junction
Phase of Trial: Phase II
Latest Information Update: 24 Dec 2009
At a glance
- Drugs Capecitabine (Primary) ; Cisplatin (Primary) ; Irinotecan (Primary)
- Indications Gastric cancer; Gastrointestinal cancer; Oesophageal cancer
- Focus Therapeutic Use
- 24 Dec 2009 Results were presented in the Annals of Oncology.
- 29 May 2009 Status changed from active, no longer recruiting to completed.
- 19 Dec 2006 New trial record.